141 related articles for article (PubMed ID: 16525503)
21. Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation.
Johnson SL; Ranxhi B; Libohova K; Tsou WL; Todi SV
Elife; 2020 Sep; 9():. PubMed ID: 32955441
[TBL] [Abstract][Full Text] [Related]
22. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
Ashraf NS; Sutton JR; Yang Y; Ranxhi B; Libohova K; Shaw ED; Barget AJ; Todi SV; Paulson HL; Costa MDC
Neurobiol Dis; 2020 Apr; 137():104697. PubMed ID: 31783119
[TBL] [Abstract][Full Text] [Related]
23. From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation.
Da Silva JD; Teixeira-Castro A; Maciel P
Neurotherapeutics; 2019 Oct; 16(4):1009-1031. PubMed ID: 31691128
[TBL] [Abstract][Full Text] [Related]
24. Toxicity and aggregation of the polyglutamine disease protein, ataxin-3 is regulated by its binding to VCP/p97 in Drosophila melanogaster.
Ristic G; Sutton JR; Libohova K; Todi SV
Neurobiol Dis; 2018 Aug; 116():78-92. PubMed ID: 29704548
[TBL] [Abstract][Full Text] [Related]
25. Interaction between the AAA ATPase p97/VCP and a concealed UBX domain in the copper transporter ATP7A is associated with motor neuron degeneration.
Yi L; Kaler SG
J Biol Chem; 2018 May; 293(20):7606-7617. PubMed ID: 29599289
[TBL] [Abstract][Full Text] [Related]
26. Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
de Assis AM; Saute JAM; Longoni A; Haas CB; Torrez VR; Brochier AW; Souza GN; Furtado GV; Gheno TC; Russo A; Monte TL; Castilhos RM; Schumacher-Schuh A; D'Avila R; Donis KC; de Mello Rieder CR; Souza DO; Camey S; Leotti VB; Jardim LB; Portela LV
Front Neurol; 2017; 8():485. PubMed ID: 28979235
[TBL] [Abstract][Full Text] [Related]
27. Interaction between the AAA
Rao MV; Williams DR; Cocklin S; Loll PJ
J Biol Chem; 2017 Nov; 292(45):18392-18407. PubMed ID: 28939772
[TBL] [Abstract][Full Text] [Related]
28. Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice.
Toonen LJA; Rigo F; van Attikum H; van Roon-Mom WMC
Mol Ther Nucleic Acids; 2017 Sep; 8():232-242. PubMed ID: 28918024
[TBL] [Abstract][Full Text] [Related]
29. The spliceosome-associated protein Mfap1 binds to VCP in Drosophila.
Rode S; Ohm H; Zipfel J; Rumpf S
PLoS One; 2017; 12(8):e0183733. PubMed ID: 28837687
[TBL] [Abstract][Full Text] [Related]
30. The AAA+ ATPase p97, a cellular multitool.
Stach L; Freemont PS
Biochem J; 2017 Aug; 474(17):2953-2976. PubMed ID: 28819009
[TBL] [Abstract][Full Text] [Related]
31. A Mighty "Protein Extractor" of the Cell: Structure and Function of the p97/CDC48 ATPase.
Ye Y; Tang WK; Zhang T; Xia D
Front Mol Biosci; 2017; 4():39. PubMed ID: 28660197
[TBL] [Abstract][Full Text] [Related]
32. The Interplay of Cofactor Interactions and Post-translational Modifications in the Regulation of the AAA+ ATPase p97.
Hänzelmann P; Schindelin H
Front Mol Biosci; 2017; 4():21. PubMed ID: 28451587
[TBL] [Abstract][Full Text] [Related]
33. Ataxin-3 consolidates the MDC1-dependent DNA double-strand break response by counteracting the SUMO-targeted ubiquitin ligase RNF4.
Pfeiffer A; Luijsterburg MS; Acs K; Wiegant WW; Helfricht A; Herzog LK; Minoia M; Böttcher C; Salomons FA; van Attikum H; Dantuma NP
EMBO J; 2017 Apr; 36(8):1066-1083. PubMed ID: 28275011
[TBL] [Abstract][Full Text] [Related]
34. The evolving role of ubiquitin modification in endoplasmic reticulum-associated degradation.
Preston GM; Brodsky JL
Biochem J; 2017 Feb; 474(4):445-469. PubMed ID: 28159894
[TBL] [Abstract][Full Text] [Related]
35. Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3.
Toonen LJ; Schmidt I; Luijsterburg MS; van Attikum H; van Roon-Mom WM
Sci Rep; 2016 Oct; 6():35200. PubMed ID: 27731380
[TBL] [Abstract][Full Text] [Related]
36. Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3.
Costa MDC; Ashraf NS; Fischer S; Yang Y; Schapka E; Joshi G; McQuade TJ; Dharia RM; Dulchavsky M; Ouyang M; Cook D; Sun D; Larsen MJ; Gestwicki JE; Todi SV; Ivanova MI; Paulson HL
Brain; 2016 Nov; 139(11):2891-2908. PubMed ID: 27645800
[TBL] [Abstract][Full Text] [Related]
37. Structure and function of the AAA+ ATPase p97/Cdc48p.
Xia D; Tang WK; Ye Y
Gene; 2016 May; 583(1):64-77. PubMed ID: 26945625
[TBL] [Abstract][Full Text] [Related]
38. Loss of RAD-23 Protects Against Models of Motor Neuron Disease by Enhancing Mutant Protein Clearance.
Jablonski AM; Lamitina T; Liachko NF; Sabatella M; Lu J; Zhang L; Ostrow LW; Gupta P; Wu CY; Doshi S; Mojsilovic-Petrovic J; Lans H; Wang J; Kraemer B; Kalb RG
J Neurosci; 2015 Oct; 35(42):14286-306. PubMed ID: 26490867
[TBL] [Abstract][Full Text] [Related]
39. The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster.
Tsou WL; Ouyang M; Hosking RR; Sutton JR; Blount JR; Burr AA; Todi SV
Neurobiol Dis; 2015 Oct; 82():12-21. PubMed ID: 26007638
[TBL] [Abstract][Full Text] [Related]
40. Molecular interaction between the chaperone Hsc70 and the N-terminal flank of huntingtin exon 1 modulates aggregation.
Monsellier E; Redeker V; Ruiz-Arlandis G; Bousset L; Melki R
J Biol Chem; 2015 Jan; 290(5):2560-76. PubMed ID: 25505179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
